Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Rotavirus vaccines: success by reassortment?

× No keyword cloud information.

13 in total

1. Rotavirus spike protein VP4 is present at the plasma membrane and is associated with microtubules in infected cells.

Authors: M Nejmeddine; G Trugnan; C Sapin; E Kohli; L Svensson; S Lopez; J Cohen
Journal: J Virol Date: 2000-04 Impact factor: 5.103

2. Probing the structure of rotavirus NSP4: a short sequence at the extreme C terminus mediates binding to the inner capsid particle.

Authors: J A O'Brien; J A Taylor; A R Bellamy
Journal: J Virol Date: 2000-06 Impact factor: 5.103

3. [2006 immunization plan--details of rotavirus vaccination].

Authors: Renate Höhl
Journal: Wien Med Wochenschr Date: 2007

4. Development and validation of DNA microarray for genotyping group A rotavirus VP4 (P[4], P[6], P[8], P[9], and P[14]) and VP7 (G1 to G6, G8 to G10, and G12) genes.

Authors: Shinjiro Honma; Vladimir Chizhikov; Norma Santos; Masatoshi Tatsumi; Maria do Carmo S T Timenetsky; Alexandre C Linhares; Joana D'Arc P Mascarenhas; Hiroshi Ushijima; George E Armah; Jon R Gentsch; Yasutaka Hoshino
Journal: J Clin Microbiol Date: 2007-06-13 Impact factor: 5.948

5. Protective efficacy of a sulfated sialyl lipid (NMSO3) against human rotavirus-induced diarrhea in a mouse model.

Authors: Kazuo Takahashi; Kazutaka Ohashi; Yurika Abe; Shuichi Mori; Koki Taniguchi; Takusaburo Ebina; Osamu Nakagomi; Masaki Terada; Shiro Shigeta
Journal: Antimicrob Agents Chemother Date: 2002-02 Impact factor: 5.191

6. Quantification of systemic and local immune responses to individual rotavirus proteins during rotavirus infection in mice.

Authors: S Ishida; N Feng; B Tang; J M Gilbert; H B Greenberg
Journal: J Clin Microbiol Date: 1996-07 Impact factor: 5.948

10. Rotavirus serotype G9 strains belonging to VP7 gene phylogenetic sequence lineage 1 may be more suitable for serotype G9 vaccine candidates than those belonging to lineage 2 or 3.

Authors: Yasutaka Hoshino; Ronald W Jones; Jerri Ross; Shinjiro Honma; Norma Santos; Jon R Gentsch; Albert Z Kapikian
Journal: J Virol Date: 2004-07 Impact factor: 5.103

Rotavirus vaccines: success by reassortment?